388 related articles for article (PubMed ID: 18585434)
1. Twenty-five years of research on bovine lactoferrin applications.
Tomita M; Wakabayashi H; Shin K; Yamauchi K; Yaeshima T; Iwatsuki K
Biochimie; 2009 Jan; 91(1):52-7. PubMed ID: 18585434
[TBL] [Abstract][Full Text] [Related]
2. Bovine lactoferrin: benefits and mechanism of action against infections.
Yamauchi K; Wakabayashi H; Shin K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):291-6. PubMed ID: 16936799
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin and prevention of late-onset sepsis in the pre-term neonates.
Manzoni P; Decembrino L; Stolfi I; Pugni L; Rinaldi M; Cattani S; Romeo MG; Messner H; Laforgia N; Vagnarelli F; Memo L; Bordignon L; Saia OS; Maule M; Gallo E; Mostert M; Magnani C; Quercia M; Bollani L; Pedicino R; Renzullo L; Betta P; Ferrari F; Magaldi R; Mosca F; Stronati M; Farina D; ;
Early Hum Dev; 2010 Jul; 86 Suppl 1():59-61. PubMed ID: 20138718
[TBL] [Abstract][Full Text] [Related]
4. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.
Nojima Y; Suzuki Y; Iguchi K; Shiga T; Iwata A; Fujimoto T; Yoshida K; Shimizu H; Takeuchi T; Sato A
Bioconjug Chem; 2008 Nov; 19(11):2253-9. PubMed ID: 18834167
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin potentially facilitates glucose regulation and enhances the incretin effect.
Maekawa Y; Sugiyama A; Takeuchi T
Biochem Cell Biol; 2017 Feb; 95(1):155-161. PubMed ID: 28177763
[TBL] [Abstract][Full Text] [Related]
6. Expression of bovine lactoferrin and lactoferrin N-lobe by recombinant baculovirus and its antimicrobial activity against Prototheca zopfii.
Tanaka T; Nakamura I; Lee NY; Kumura H; Shimazaki K
Biochem Cell Biol; 2003 Oct; 81(5):349-54. PubMed ID: 14569298
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
8. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
9. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.
Jiang R; Lönnerdal B
Biochem Cell Biol; 2017 Feb; 95(1):99-109. PubMed ID: 28169560
[TBL] [Abstract][Full Text] [Related]
10. The anti-papillomavirus activity of human and bovine lactoferricin.
Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.
Jiang R; Du X; Lönnerdal B
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):642-52. PubMed ID: 25000352
[TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
Marr AK; Jenssen H; Moniri MR; Hancock RE; Panté N
Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
[TBL] [Abstract][Full Text] [Related]
13. Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens.
Lacasse P; Lauzon K; Diarra MS; Petitclerc D
J Anim Sci; 2008 Mar; 86(13 Suppl):66-71. PubMed ID: 17565052
[TBL] [Abstract][Full Text] [Related]
14. Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin.
Murata M; Wakabayashi H; Yamauchi K; Abe F
J Dairy Sci; 2013 Aug; 96(8):4891-8. PubMed ID: 23769363
[TBL] [Abstract][Full Text] [Related]
15. Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes.
Furlund CB; Ulleberg EK; Devold TG; Flengsrud R; Jacobsen M; Sekse C; Holm H; Vegarud GE
J Dairy Sci; 2013 Jan; 96(1):75-88. PubMed ID: 23141828
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin.
Pan Y; Wan J; Roginski H; Lee A; Shiell B; Michalski WP; Coventry MJ
Lett Appl Microbiol; 2007 Mar; 44(3):229-34. PubMed ID: 17309497
[TBL] [Abstract][Full Text] [Related]
17. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues.
Fischer R; Debbabi H; Blais A; Dubarry M; Rautureau M; Boyaka PN; Tome D
Int Immunopharmacol; 2007 Oct; 7(10):1387-93. PubMed ID: 17673154
[TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
19. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG).
Zimecki M; Machnicki M
Arch Immunol Ther Exp (Warsz); 1994; 42(3):171-7. PubMed ID: 7487348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
